JP2022527162A5 - - Google Patents
Info
- Publication number
- JP2022527162A5 JP2022527162A5 JP2021557247A JP2021557247A JP2022527162A5 JP 2022527162 A5 JP2022527162 A5 JP 2022527162A5 JP 2021557247 A JP2021557247 A JP 2021557247A JP 2021557247 A JP2021557247 A JP 2021557247A JP 2022527162 A5 JP2022527162 A5 JP 2022527162A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- optionally
- domain
- transmembrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962823711P | 2019-03-26 | 2019-03-26 | |
| US62/823,711 | 2019-03-26 | ||
| US201962898471P | 2019-09-10 | 2019-09-10 | |
| US62/898,471 | 2019-09-10 | ||
| PCT/IL2020/050360 WO2020194306A1 (en) | 2019-03-26 | 2020-03-26 | Genetically reprogrammed tregs expressing cars |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527162A JP2022527162A (ja) | 2022-05-31 |
| JP2022527162A5 true JP2022527162A5 (https=) | 2023-04-03 |
Family
ID=72610330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557247A Pending JP2022527162A (ja) | 2019-03-26 | 2020-03-26 | Ｃａｒを発現する遺伝的にリプログラミングされたｔｒｅｇ |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220186232A1 (https=) |
| EP (1) | EP3947690A4 (https=) |
| JP (1) | JP2022527162A (https=) |
| KR (1) | KR20210143856A (https=) |
| CN (1) | CN114127297A (https=) |
| AU (1) | AU2020245329A1 (https=) |
| CA (1) | CA3134878A1 (https=) |
| IL (1) | IL286644A (https=) |
| WO (1) | WO2020194306A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019291069B2 (en) * | 2018-06-19 | 2026-02-19 | Fondazione Centro San Raffaele | Production of engineered dendritic cells and uses thereof |
| EP4288072A4 (en) * | 2021-02-02 | 2025-10-08 | Carisma Therapeutics Inc | SELF-POLARIZING IMMUNE CELLS |
| EP4444361A4 (en) * | 2021-12-09 | 2025-12-10 | Carisma Therapeutics Inc | IN VIVO ADMINISTRATION TO IMMUNE CELLS |
| WO2023129929A1 (en) * | 2021-12-30 | 2023-07-06 | Tr1X, Inc. | Cd4+ t cells expressing il-10 and chimeric antigen receptors and uses thereof |
| CN117402257B (zh) * | 2023-09-13 | 2025-08-26 | 武汉大学 | 人工病毒受体及其应用 |
| WO2025148750A1 (zh) * | 2024-01-08 | 2025-07-17 | 上药生物治疗（香港）有限公司 | 膜表达il-10及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4596769A (en) * | 1984-03-05 | 1986-06-24 | Temple University | Monoclonal antibodies to peptidoglycan and methods of preparing same |
| AU5275100A (en) * | 1999-05-21 | 2000-12-12 | Regents Of The University Of California, The | Fluorescent protein indicators |
| AU2001264902A1 (en) * | 2000-05-24 | 2001-12-03 | Cel-Sci Corporation | T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders |
| ATE509025T1 (de) * | 2002-06-12 | 2011-05-15 | Gavish Galilee Bio Appl Ltd | ßMIT MHC-KLASSE-I-PEPTIDEPITOPEN KOVALENT VERKN PFTES MEMBRANVERANKERTES BETA2-MIKROGLOBULINß |
| JP5830744B2 (ja) * | 2009-08-19 | 2015-12-09 | 国立大学法人東京工業大学 | 乳酸菌の付着性を誘導するペプチド及びその用途 |
| EP4282419A1 (en) * | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| GB201317929D0 (en) * | 2013-10-10 | 2013-11-27 | Ucl Business Plc | Chimeric antigen receptor |
| US10093717B2 (en) * | 2015-08-07 | 2018-10-09 | Shenzhen In Vivo Biomedicine Technology Limited Company | Chimeric antigen receptor containing a toll-like receptor intracellular domain |
| US11365391B2 (en) * | 2015-09-28 | 2022-06-21 | Trustees Of Dartmouth College | Chimeric antigen receptor anti-inflammatory cells and methods of use |
| EP3443002A4 (en) * | 2016-04-14 | 2019-12-04 | Bluebird Bio, Inc. | SYSTEMS FOR RECOVERED CHIMERIC ANTIGEN RECEPTORS |
| BR112019006006A2 (pt) * | 2016-09-28 | 2019-06-25 | Gavish-Galilee Bio Applications Ltd. | molécula de ácido nucleico, vetor, métodos para preparação de um receptor de antígeno quimérico inibidor, para preparar uma célula imune efetora segura, para selecionar um biomarcador personalizado e para tratar o câncer em um paciente com um tumor, célula imune efetora segura, e, combinação de duas ou mais moléculas de ácido nucleico. |
| SG11202001011XA (en) * | 2017-08-23 | 2020-03-30 | Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft | Chimeric antigen receptor and car-t cells that bind cxcr5 |
| AU2019240370B2 (en) * | 2018-03-23 | 2024-03-07 | Gavish-Galilee Bio Applications Ltd. | Genetically reprogrammed Tregs expressing membrane-bound IL-10 |
-
2020
- 2020-03-26 CN CN202080038509.9A patent/CN114127297A/zh active Pending
- 2020-03-26 KR KR1020217034307A patent/KR20210143856A/ko not_active Ceased
- 2020-03-26 JP JP2021557247A patent/JP2022527162A/ja active Pending
- 2020-03-26 AU AU2020245329A patent/AU2020245329A1/en not_active Abandoned
- 2020-03-26 EP EP20778842.3A patent/EP3947690A4/en active Pending
- 2020-03-26 US US17/598,208 patent/US20220186232A1/en active Pending
- 2020-03-26 CA CA3134878A patent/CA3134878A1/en active Pending
- 2020-03-26 WO PCT/IL2020/050360 patent/WO2020194306A1/en not_active Ceased
-
2021
- 2021-09-23 IL IL286644A patent/IL286644A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527162A5 (https=) | ||
| KR102646495B1 (ko) | 재조합 pMHC II형 분자 | |
| US11884716B2 (en) | Compositions and methods of phospholipase A2 receptor chimeric autoantibody receptor T cells | |
| KR102488477B1 (ko) | 신속하고 포괄적인 t-세포 면역 모니터링을 위한 세포 플랫폼 | |
| US20250074960A1 (en) | Multimeric t-cell modulatory polypeptides and methods of use thereof | |
| JP2021519107A5 (https=) | ||
| JP2023520205A5 (https=) | ||
| KR20180132663A (ko) | T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법 | |
| CN110268050A (zh) | 经修饰的t细胞和它们的使用方法 | |
| JP2018525006A5 (https=) | ||
| CN107074929A (zh) | 嵌合自身抗体受体t细胞的组合物和方法 | |
| RU2020109577A (ru) | Клетка | |
| MX2007014919A (es) | Receptores de celulas t de melan-a de alta afinidad. | |
| JP2019513394A (ja) | キメラアロ抗原受容体ｔ細胞の組成物および方法 | |
| CN111819186A (zh) | 表达嵌合抗原受体的免疫细胞 | |
| JP2022510276A5 (https=) | ||
| JP2021520820A5 (https=) | ||
| EP4370542A2 (en) | Compositions and methods for making novel t-cell receptors | |
| WO2020018691A1 (en) | Modified t cells and methods of their use | |
| JP2022527813A (ja) | Ｍａｇｅａ１特異的ｔ細胞受容体およびその使用 | |
| WO2023010118A1 (en) | Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the same | |
| CA2634292A1 (en) | Apoptosis-inducing protein complexes and therapeutic use thereof | |
| US20250073265A1 (en) | Compositions and Methods of Chimeric Autoantibody Receptor Cells Expressing Extended Phospholipase A2 Receptor Fragments | |
| Richardson et al. | Definition of polymorphic residues on killer Ig‐like receptor proteins which contribute to the HLA‐C binding site | |
| US20120177671A1 (en) | Hla-g alpha 1 multimers and pharmaceutical uses thereof |